Anticarin-β shows a promising anti-osteosarcoma effect by specifically inhibiting CCT4 to impair proteostasis.
Wang G, Zhang M, Meng P, Long C, Luo X, Yang X, Wang Y, Zhang Z, Mwangi J, Kamau PM, Dai Z, Ke Z, Zhang Y, Chen W, Zhao X, Ge F, Lv Q, Rong M, Li D, Jin Y, Sheng X, Lai R.
Wang G, et al.
Acta Pharm Sin B. 2022 May;12(5):2268-2279. doi: 10.1016/j.apsb.2021.12.024. Epub 2022 Jan 4.
Acta Pharm Sin B. 2022.
PMID: 35646538
Free PMC article.